ECM
ExodusPoint Capital Management Portfolio holdings
AUM
$8.21B
1-Year Return
14.38%
This Quarter Return
+9.27%
1 Year Return
+14.38%
3 Year Return
+47.96%
5 Year Return
+100.26%
10 Year Return
–
AUM
$3.38B
AUM Growth
-$43.6M
(-1.3%)
Cap. Flow
-$233M
Cap. Flow
% of AUM
-6.91%
Top 10 Holdings %
Top 10 Hldgs %
13.61%
Holding
2,405
New
694
Increased
403
Reduced
519
Closed
774
Top Buys
| 1 |
Charles Schwab
SCHW
|
+$67M |
| 2 |
Alibaba
BABA
|
+$39.5M |
| 3 |
Apple
AAPL
|
+$36.4M |
| 4 |
DuPont de Nemours
DD
|
+$35.4M |
| 5 |
Generac Holdings
GNRC
|
+$32M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$82.1M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$46.4M |
| 3 |
NBIS
Nebius Group N.V. Class A Ordinary Shares
NBIS
|
+$40.7M |
| 4 |
Comcast
CMCSA
|
+$40.5M |
| 5 |
PG&E
PCG
|
+$31.6M |
Sector Composition
| 1 | Technology | 15.99% |
| 2 | Financials | 15.33% |
| 3 | Healthcare | 11.92% |
| 4 | Industrials | 11.5% |
| 5 | Consumer Discretionary | 11.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1326
Agilent Technologies
A
$34.9B
| $245K | ﹤0.01% |
+2,423
| New | +$245K |
|
1327
Coherus Oncology, Inc. Common Stock
CHRS
$150M
| $245K | ﹤0.01% |
+13,345
| New | +$245K |
|
|
ADAP
1328
Adaptimmune Therapeutics
ADAP
$14.8M
| $244K | ﹤0.01% |
+30,607
| New | +$244K |
|
|
NXRT
1329
NexPoint Residential Trust
NXRT
$858M
| $244K | ﹤0.01% |
5,503
-3,578
| -39% | -$159K |
|
1330
Ultragenyx Pharmaceutical
RARE
$2.92B
| $244K | ﹤0.01% |
+2,965
| New | +$244K |
|
1331
Astronics
ATRO
$1.41B
| $243K | ﹤0.01% |
31,532
+17,843
| +130% | +$138K |
|
1332
FibroGen
FGEN
$48.6M
| $242K | ﹤0.01% |
+235
| New | +$242K |
|
1333
Atlanta Braves Holdings Series B
BATRK
$2.64B
| $241K | ﹤0.01% |
+11,471
| New | +$241K |
|
1334
Midland States Bancorp
MSBI
$385M
| $241K | ﹤0.01% |
+18,793
| New | +$241K |
|
1335
Yelp
YELP
$1.95B
| $241K | ﹤0.01% |
+11,997
| New | +$241K |
|
1336
Mid-America Apartment Communities
MAA
$16.6B
| $240K | ﹤0.01% |
2,066
-13,422
| -87% | -$1.56M |
|
|
RAVN
1337
DELISTED
Raven Industries Inc
RAVN
| $239K | ﹤0.01% |
+11,113
| New | +$239K |
|
|
AKCA
1338
DELISTED
Akcea Therapeutics, Inc. Common Stock
AKCA
| $238K | ﹤0.01% |
13,111
-33,425
| -72% | -$607K |
|
1339
Kontoor Brands
KTB
$4.5B
| $237K | ﹤0.01% |
+9,799
| New | +$237K |
|
1340
Schrodinger
SDGR
$1.37B
| $237K | ﹤0.01% |
+4,988
| New | +$237K |
|
1341
Vital Energy
VTLE
$635M
| $237K | ﹤0.01% |
24,192
+7,704
| +47% | +$75.5K |
|
|
CVET
1342
DELISTED
Covetrus, Inc. Common Stock
CVET
| $237K | ﹤0.01% |
9,694
-21,290
| -69% | -$521K |
|
|
PTR
1343
DELISTED
PETROCHINA COMPANY LIMITED ADS (REP 100 H SHARES)
PTR
| $237K | ﹤0.01% |
+8,038
| New | +$237K |
|
|
AVDL
1344
Avadel Pharmaceuticals
AVDL
$1.5B
| $236K | ﹤0.01% |
+46,731
| New | +$236K |
|
1345
Medical Properties Trust
MPW
$3.08B
| $236K | ﹤0.01% |
13,382
-22,628
| -63% | -$399K |
|
1346
Prothena Corp
PRTA
$442M
| $235K | ﹤0.01% |
23,500
+11,012
| +88% | +$110K |
|
1347
TriNet
TNET
$3.35B
| $235K | ﹤0.01% |
3,959
-3,142
| -44% | -$187K |
|
|
CMD
1348
DELISTED
Cantel Medical Corporation
CMD
| $234K | ﹤0.01% |
5,333
-5,044
| -49% | -$221K |
|
1349
Boot Barn
BOOT
$5.4B
| $233K | ﹤0.01% |
8,288
-51,287
| -86% | -$1.44M |
|
1350
Innoviva
INVA
$1.22B
| $233K | ﹤0.01% |
+22,318
| New | +$233K |
|